In this work, we report a complex in vitro model of the human intestinal interface mimicking IBD pathophysiology that allows the combined investigation of intestinal barrier crossing as well as efficacy and target engagement of drug/delivery systems exploiting JAK/STAT pathway inhibition. The gene discussed is SOAT1; the disease is inflammatory bowel disease.